Dietary management of insulin resistance and the metabolic syndrome

被引：0

作者：

Josse A.R. ^{[1
]}

Kendall C.W.C. ^{[1
]}

Jenkins D.J.A. ^{[1
]}

机构：

[1] Clinical Nutrition and Risk Factor Modification Center, St. Michael's Hospital, Toronto, ON, M5C 2T2

来源：

Current Cardiovascular Risk Reports | 2007年 / 1卷 / 1期

关键词：

Metabolic Syndrome; Acarbose; Ketogenic Diet; Repaglinide; Glycemic Load;

D O I：

10.1007/s12170-007-0005-9

中图分类号：

学科分类号：

摘要：

Strategies are being developed to reduce the incidence of diabetes and other associated chronic diseases, including heart disease and many common cancers. Part of the strategy has been to define at-risk groups, especially those with the metabolic syndrome. Perhaps the most readily useable classification is that of National Cholesterol Education Program Adult Treatment Panel III criteria. The ultimate goal has been to increase exercise and reduce body weight. Diets with different macronutrient profiles have been proposed, all of which appear useful if compliance is maintained but may differ somewhat in the spectrum of benefits they confer. Newer drugs have appeared that also may confer benefit metabolically (peroxisome proliferator-activated receptor agonists) or by central mechanisms (cannabinoid antagonists). The changes will likely have to be metabolic and societal and include not only the food industry but also modes of transportation and urban planning. © 2007 Current Medicine Group LLC.

引用

页码：24 / 31

页数：7

共 70 条

[1]

Reaven G.M., The metabolic syndrome: is this diagnosis necessary?, Am J Clin Nutr, 83, pp. 1237-1247, (2006)

[2]

Park Y.W., Zhu S., Palaniappan L., Et al., The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994, Arch Intern Med, 163, pp. 427-436, (2003)

[3]

National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Circulation, 106, pp. 3143-3421, (2002)

[4]

Grundy S.M., Cleeman J.I., Daniels S.R., Et al., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, pp. 2735-2752, (2005)

[5]

Alberti K.G., Zimmet P.Z., Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation, Diabet Med, 15, pp. 539-553, (1998)

[6]

Zimmet P., Magliano D., Matsuzawa Y., Et al., The metabolic syndrome: a global public health problem and a new definition, J Atheroscler Thromb, 12, pp. 295-300, (2005)

[7]

Alberti K.G., Zimmet P., Shaw J., Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation, Diabet Med, 23, pp. 469-480, (2006)

[8]

Dansinger M.L., Gleason J.A., Griffith J.L., Et al., Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial, Jama, 293, pp. 43-53, (2005)

[9]

Foster G.D., Wyatt H.R., Hill J.O., Et al., A randomized trial of a low-carbohydrate diet for obesity, N Engl J Med, 348, pp. 2082-2090, (2003)

[10]

Stern L., Iqbal N., Seshadri P., Et al., The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial, Ann Intern Med, 140, pp. 778-785, (2004)

← 1 2 3 4 5 6 7 →